BSX
US EQUITY
Health Care
Health Care Equipment
CIK: 885725
Boston Scientific (BSX) Quant Factor Diagnostic & Fair Value Model
Boston Scientific (Ticker: BSX) is listed in the Health Care sector (Health Care Equipment). Below is its point-in-time financial profile, valuation multiples, and cross-sectional factor diagnostics.
$45.69
-0.70%
Latest Close (2026-10-23)
Market Cap: $66.22B
P/E Ratio: 18.7
Momentum Strength
3M / 12M
+0.40%
1M: +2.26%
12M: -56.00%
Quality (ROE)
Point-in-Time
-
Trailing Return on Equity
Technical Trend
RSI 14
67.5
SMA50: $45.54
SMA200: $57.83
Valuation Multiplier
Trailing
18.7
Moderate Valuation Corridor (15x - 30x P/E)
📊
Valuation & Multi-Factor Diagnostic
Moderate Valuation Corridor (15x - 30x P/E)
BSX trades within a typical sector multiple band (18.7x P/E), broadly aligned with trailing earnings.
⚡
Benchmark Factor Strategy
S&P 500 Momentum Alpha Strategy
This strategy applies cross-sectional momentum and quality factor filters across large-cap US equities.
📈 Daily Candlestick & Volume Quant Chart
Interactive lightweight price action & volume breakdown over recent 90 trading days.
均线整理 (MA20/50)
Piotroski F-Score: 4/9 (Moderate Financial Health)
Official Point-in-Time Financial Filing History
Zero Lookahead Bias: Every financial metric is timestamped at the exact moment officially published to the market.
备案 CIK: 885725 · 10-K 年报 / 10-Q 季报
| Form | Period End | Filing Timestamp (Point-in-Time) | Revenue | Net Income | Operating CF | EPS (Diluted) |
|---|---|---|---|---|---|---|
| 10-Q | 2026-06-30 | 2026-08-03 | - | - | $1.82B | $0.61 |
| 10-Q | 2025-12-31 | 2026-08-03 | - | - | - | - |
| 10-Q | 2025-06-30 | 2026-08-03 | - | - | $1.83B | $0.53 |
| 10-Q | 2026-03-31 | 2026-05-01 | - | - | $348.00M | $0.90 |
| 10-Q | 2025-03-31 | 2026-05-01 | - | - | $541.00M | $0.45 |
| 10-K | 2025-12-31 | 2026-02-17 | - | - | $4.53B | $1.94 |
| 10-K | 2024-12-31 | 2026-02-17 | - | - | $3.44B | $1.25 |
| 10-K | 2023-12-31 | 2026-02-17 | - | - | $2.50B | $1.07 |
💡 Methodology & Frequently Asked Questions
Key reference details regarding Boston Scientific (BSX) valuation multiples, momentum factors, and point-in-time filing conventions.
How should BSX's current valuation multiple be interpreted? ↓
BSX trades at a trailing P/E of 18.7x within the Health Care sector (moderate valuation corridor (15x - 30x p/e)). Valuation multiples are computed using trailing-twelve-month GAAP earnings against the latest close price.
What are BSX's key momentum and technical factor indicators? ↓
As of the latest close, BSX shows a 1-month return of +2.26%, 3-month return of +0.40%, and 12-month return of -56.00%, with a 14-day RSI of 67.5. Momentum factors reflect short- and intermediate-term price velocity across the equity cross-section.
What is Point-in-Time (PIT) financial data and why does it matter for BSX? ↓
Point-in-Time indexing aligns corporate fundamentals with their official public filing timestamps (Form 10-Q/10-K) rather than accounting period-end dates. This methodology eliminates lookahead bias in historical equity backtests.
How can BSX be incorporated into systematic factor models? ↓
BSX can be evaluated within customized multi-factor models or screened against cross-sectional filters (such as momentum quintiles and return on equity) to analyze historical turnover and risk-adjusted return.